Basics RenovoRx, Inc. IPO Date: August 26, 2021 Sector: Healthcare Industry: Biotech Market Cap: $34.5M Activated in VL: True Average Daily Range Avg Daily Range: $0.12 | 4.67% Avg Daily Range (30 D): $0.04 | 4.12% Avg Daily Range (90 D): $0.04 | 4.05% Institutional Daily Volume Avg Daily Volume: .3M Avg Daily Volume (30 D): .26M Avg Daily Volume (90 D): .41M Trade Size Avg Trade Size (Sh.): 175 Avg Trade Size (Sh.) (30 D): 342 Avg Trade Size (Sh.) (90 D): 393 Institutional Trades Total Inst.Trades: 8 Avg Inst. Trade: $1.13M Avg Inst. Trade (30 D): $M Avg Inst. Trade (90 D): $M Avg Inst. Trade Volume: .1M Avg Inst. Trades (Per Day): 2 Market Closing Trades Avg Closing Trade: $M Avg Closing Trade (30 D): $M Avg Closing Trade (90 D): $M Avg Closing Volume: K     News Jun 26, 2024 @ 12:30 PM University of Nebraska Medical Center Launches Pat... Source: RenovoRx, Inc. Jun 10, 2024 @ 12:30 PM RenovoRx Appoints Ryan Witt as Senior Vice Preside... Source: RenovoRx, Inc. Jan 2, 2024 @ 6:35 PM Why Longboard Pharmaceuticals Shares Are Trading H... Source: Avi Kapoor Dec 28, 2023 @ 6:07 PM Why DouYu International Shares Are Trading Higher ... Source: Avi Kapoor Jun 30, 2023 @ 10:00 AM What to Look for in a Penny Stocks Trading Platfor... Source: D. Marie Financials   TTM Q3 2025 Q2 2025 Basic EPS $-.36 $-.08 $-.08 Diluted EPS $-.36 $-.08 $-.08 Revenue $ .63M $ .21M $ .27M Gross Profit $ $ $ Net Income / Loss $ -11.11M $ -2.91M $ -2.9M Operating Income / Loss $ -11.62M $ -3.2M $ -2.68M Cost of Revenue $ $ $ Net Cash Flow $ 5.98M $ M $ M PE Ratio